United Therapeutics Completes TETON-PPF Phase 3 Enrollment
Silver Spring, Maryland & Research Triangle Park, North Carolina — August 17, 2026 United Therapeutics Corporation announced the full...
Phase 3 Clinical Trial
Advertisement
AstraZeneca Discontinues eVOLVE-Lung02 Phase 3 Trial
Cambridge, UK — August 17, 2026 AstraZeneca announced that it is discontinuing the eVOLVE-Lung02 Phase III trial evaluating volrustomig...
Acurx Advances Ibezapolstat Toward Phase 3 Development
Staten Island, New York, August 17, 2026 Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company developing antibiotics for difficult-to-treat bacterial...
Henlius and Sandoz Expand Global Strategic Biosimilar Effort
Shanghai, China, August 17, 2026 Shanghai Henlius Biotech, Inc. and Sandoz have entered into a strategic collaboration to expand...
Daiichi Sankyo and AstraZeneca Report Enhertu Phase 3 Win
Tokyo, Japan — August 17, 2026 Daiichi Sankyo and AstraZeneca announced positive topline results from the DESTINY-Lung04 Phase 3...
Advertisements
Mesoblast Completes Treatment in Phase 3 Low Back Pain Trial
New York, USA / Melbourne, Australia August 17, 2026: Mesoblast Limited has completed patient treatment in its pivotal Phase...
LeonaBio Advances Lasofoxifene Phase 3 Breast Cancer Trial
BOTHELL, Wash., Aug. 14, 2026 LeonaBio, Inc. reported continued progress in the Phase 3 ELAINE-3 clinical trial evaluating lasofoxifene...
Helus Pharma Completes Phase 3 HLP003 Enrollment in MDD
NEW YORK and TORONTO, Aug. 14, 2026 Helus Pharma is advancing its late-stage clinical development strategy for novel serotonergic...
Annovis Advances Buntanetap in Alzheimer’s Phase 3
Malvern, Pennsylvania — August 14, 2026 Annovis Bio, Inc. announced that its pivotal Phase 3 Alzheimer’s disease trial of...
Freenome Gains FDA Breakthrough Device Designation
Brisbane, California, August 12, 2026 Freenome, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough...
Advertisement
